IFFIm Vaccine Bond issuance named 2019 "Deal of the Year" by mtn-i
IFFIm Vaccine Bond issuance named 2019 "Deal of the Year" by mtn-i
6 February 2020
IFFIm Vaccine Bond issuance named 2019 “Deal of the Year” by mtn-i
London, 6 February 2020 - IFFIm, Skandinaviska Enskilda Banken (SEB) and the Toronto-Dominion Bank have been awarded SRI “Deal of the Year” by news, data and analytics publisher mtn-i for a July 2019 Vaccine Bond issuance that raised funding to research and develop new vaccines.
The award was given in the SRI: Green/Social category for IFFIm’s July 2019 issuance that raised 600 million Norwegian krone (US$ 65 million) for CEPI, the Coalition for Epidemic Preparedness Innovations. CEPI is a public private initiative that accelerates development of vaccines against emerging infectious diseases and enables equitable access to these vaccines during outbreaks. These bonds provided immediate funding to combat diseases like MERS, Nipah virus and Lassa fever.
The transaction allowed Norway to accelerate its multi-year pledge to CEPI by leveraging IFFIm’s access to the capital markets. Norway is a donor to IFFIm, Gavi and CEPI.
“The recognition you're giving IFFIm today is a strong validation of the growth of socially responsible investing, which is aimed at solving difficult global development challenges,” said IFFIm board chair Cyrus Ardalan, who accepted the award on February 6 in London.
“This award represents the vital engagement of the private sector to support the research and development of vaccines that fight epidemics. The current outbreak of coronavirus reminds us of how critical this work is. In fact, CEPI has been supporting a number of companies and institutes around the world that are racing to produce a new coronavirus vaccine.”
The editors at mtn-i have been strong supporters of Gavi, the Vaccine Alliance for which IFFIm raises funds in the capital markets. mtn-i has organised charity auctions at past awards ceremonies to benefit Gavi, raising £20,000 (US$ 30,000).
Today’s award is the latest of a number of awards recognizing IFFIm. mtn-i named IFFIm SRI Innovation of the Decade in 2013, and IFFIm’s Sukuks, an Islamic certificate, and Japanese retail Uridashi have been cited by financial media as top-rated, award-winning transactions. Fitch Ratings, Moody's Investor Service and Standard & Poor's have rated IFFIm as AA/Aa1/AA. For 2019, IFFIm also received an A+ rating for efficiency, economy and effectiveness from the U.K.’s Department for International Development (DFID).
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.